Raras
Buscar doenças, sintomas, genes...
Leucoencefalopatia megalencefálica com cistos subcorticais
ORPHA:2478CID-10 · E75.2CID-11 · 8A44.3DOENÇA RARA

A Leucoencefalopatia Megalencefálica com Cistos Subcorticais (LMC) é um tipo de leucodistrofia, ou seja, uma doença que afeta a substância branca do cérebro. Ela se caracteriza por um aumento do tamanho da cabeça (macrocefalia) que surge na infância, muitas vezes com sinais neurológicos leves no início (como um atraso discreto no desenvolvimento motor). Esses sinais pioram com o tempo, levando a dificuldades para andar, quedas, falta de coordenação motora (ataxia), rigidez muscular (espasticidade), aumento das crises convulsivas e declínio das funções cognitivas (perda de memória e raciocínio). A ressonância magnética do cérebro revela que a substância branca está alterada em várias áreas e levemente inchada, além de mostrar cistos (pequenas bolsas com líquido) abaixo da camada mais externa do cérebro. Esses cistos são encontrados nas regiões da frente e laterais (temporal anterior) e na parte da frente e de cima (frontoparietal).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Leucoencefalopatia Megalencefálica com Cistos Subcorticais (LMC) é um tipo de leucodistrofia, ou seja, uma doença que afeta a substância branca do cérebro. Ela se caracteriza por um aumento do tamanho da cabeça (macrocefalia) que surge na infância, muitas vezes com sinais neurológicos leves no início (como um atraso discreto no desenvolvimento motor). Esses sinais pioram com o tempo, levando a dificuldades para andar, quedas, falta de coordenação motora (ataxia), rigidez muscular (espasticidade), aumento das crises convulsivas e declínio das funções cognitivas (perda de memória e raciocínio). A ressonância magnética do cérebro revela que a substância branca está alterada em várias áreas e levemente inchada, além de mostrar cistos (pequenas bolsas com líquido) abaixo da camada mais externa do cérebro. Esses cistos são encontrados nas regiões da frente e laterais (temporal anterior) e na parte da frente e de cima (frontoparietal).

Pesquisas ativas
1 ensaio
2 total registrados no ClinicalTrials.gov
Publicações científicas
199 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
100
pacientes catalogados
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 20%
CID-10: E75.2
🇧🇷Dados SUS / DATASUS2024
890
internações/ano
R$ 45.670
custo médio/internação
ESTADOS COM MAIS INTERNAÇÕES
SPRJMGRSPR
PROCEDIMENTOS SIGTAP (8)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)enzyme_replacement
0202080013
Teste do pezinho (triagem neonatal)rehabilitation
0303050101
Infusão de imiglucerase (Gaucher)
+2 outros procedimentos
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
23 sintomas
💪
Músculos
1 sintomas
🫃
Digestivo
1 sintomas
❤️
Coração
1 sintomas

+ 10 sintomas em outras categorias

Características mais comuns

55%prev.
Ataxia
Frequente (79-30%)
55%prev.
Convulsão
Frequente (79-30%)
55%prev.
Comportamento atípico
Frequente (79-30%)
55%prev.
Marcha instável
Frequente (79-30%)
55%prev.
Deterioração mental
Frequente (79-30%)
55%prev.
Edema difuso da substância branca cerebral
Frequente (79-30%)
36sintomas
Frequente (10)
Ocasional (8)
Sem dados (18)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 36 características clínicas mais associadas, ordenadas por frequência.

Ataxia
Frequente (79-30%)55%
ConvulsãoSeizure
Frequente (79-30%)55%
Comportamento atípicoAtypical behavior
Frequente (79-30%)55%
Marcha instávelUnsteady gait
Frequente (79-30%)55%
Deterioração mentalMental deterioration
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico199PubMed
Últimos 10 anos114publicações
Pico201613 papers
Linha do tempo
2026Hoje · 2026🧪 2016Primeiro ensaio clínico📈 2016Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

MLC1Membrane protein MLC1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transmembrane protein mainly expressed in brain astrocytes that may play a role in transport across the blood-brain and brain-cerebrospinal fluid barriers (PubMed:22328087). Regulates the response of astrocytes to hypo-osmosis by promoting calcium influx (PubMed:22328087). May function as regulatory protein of membrane protein complexes such as ion channels (Probable)

LOCALIZAÇÃO

MembraneCell membraneCytoplasm, perinuclear regionEndoplasmic reticulum

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Megalencephalic leukoencephalopathy with subcortical cysts 1

A syndrome of cerebral leukoencephalopathy and megalencephaly characterized by ataxia, spasticity, seizures, delay in motor development and mild intellectual disability. The brain appears swollen on magnetic resonance imaging, with diffuse white-matter abnormalities and the invariable presence of subcortical cysts in frontal and temporal lobes.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Caudate basal ganglia
186.8 TPM
Brain Nucleus accumbens basal ganglia
180.5 TPM
Brain Anterior cingulate cortex BA24
169.7 TPM
Córtex cerebral
161.6 TPM
Cérebro - Amígdala
152.7 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
megalencephalic leukoencephalopathy with subcortical cysts 1megalencephalic leukoencephalopathy with subcortical cysts
HGNC:17082UniProt:Q15049
HEPACAMHepatic and glial cell adhesion moleculeDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in regulating cell motility and cell-matrix interactions. May inhibit cell growth through suppression of cell proliferation (PubMed:15885354, PubMed:15917256). In glia, associates and targets CLCN2 at astrocytic processes and myelinated fiber tracts where it may regulate transcellular chloride flux involved in neuron excitability (PubMed:22405205)

LOCALIZAÇÃO

CytoplasmCell membrane

MECANISMO DE DOENÇA

Megalencephalic leukoencephalopathy with subcortical cysts 2A

A neurodegenerative disorder characterized by infantile-onset macrocephaly and later onset of motor deterioration, with ataxia and spasticity, seizures, and cognitive decline of variable severity. The brain appears swollen on magnetic resonance imaging with white-matter abnormalities and subcortical cysts, in all stages of the disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Córtex cerebral
57.6 TPM
Brain Caudate basal ganglia
54.5 TPM
Brain Spinal cord cervical c-1
53.7 TPM
Brain Anterior cingulate cortex BA24
48.7 TPM
Cérebro - Amígdala
45.2 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (4)
megalencephalic leukoencephalopathy with subcortical cysts 2Amegalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disabilitymegalencephalic leukoencephalopathy with subcortical cystsmacrocephaly-autism syndrome
HGNC:26361UniProt:Q14CZ8

Variantes genéticas (ClinVar)

433 variantes patogênicas registradas no ClinVar.

🧬 HEPACAM: GRCh38/hg38 11q24.1-25(chr11:123345328-135064169)x1 ()
🧬 HEPACAM: GRCh37/hg19 11q23.3-24.2(chr11:115887338-126148523)x3 ()
🧬 HEPACAM: NM_152722.5(HEPACAM):c.901G>A (p.Glu301Lys) ()
🧬 HEPACAM: NM_152722.5(HEPACAM):c.265G>C (p.Gly89Arg) ()
🧬 HEPACAM: NM_152722.5(HEPACAM):c.286C>T (p.Arg96Ter) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 453 variantes classificadas pelo ClinVar.

91
362
Patogênica (20.1%)
VUS (79.9%)
VARIANTES MAIS SIGNIFICATIVAS
HEPACAM: NM_152722.5(HEPACAM):c.265G>C (p.Gly89Arg) [Pathogenic]
MLC1: NM_015166.4(MLC1):c.820A>C (p.Thr274Pro) [Likely pathogenic]
MLC1: NM_015166.4(MLC1):c.322-5T>C [Likely pathogenic]
MLC1: NM_015166.4(MLC1):c.424-10_525+8del [Likely pathogenic]
MLC1: NM_015166.4(MLC1):c.322-12_322-8del [Uncertain significance]

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Leucoencefalopatia megalencefálica com cistos subcorticais

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

2 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
107 papers (10 anos)
#1

Megalencephalic leukoencephalopathy with subcortical cysts: a multicenter Italian experience.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026 Jan 02

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare inherited white matter disorder. Initially, a "classic" phenotype has been characterized, presenting early-onset macrocephaly, cerebellar ataxia, mild spasticity, and a distinctive neuroimaging pattern of diffuse white matter abnormalities with subcortical cysts. An "improving" phenotype has also been described, featuring milder or absent neurological signs and a remitting pattern on neuroimaging. Mutations in four genes, MLC1, HEPACAM, GPRC5B and AQP4 have been associated with MLC. We describe clinical and genetic features of a cohort of genetically confirmed Italian MLC patients, representing the largest Italian cohort reported to date. We conducted a retrospective, multicenter, observational study. Patients were included based on clinical and neuroimaging features consistent with MLC, along with a confirmed genetic diagnosis. Data were collected using a standardized database and included demographic, clinical, neuroimaging, neurophysiological, and genetic information. Thirty-three patients from eight Italian centers were enrolled. Twenty-seven harbored biallelic MLC1 variants (23 distinct mutations, including three novel variants), while six had three distinct heterozygous HEPACAM variants. All MLC1-mutated patients exhibited the "classic" phenotype, frequently accompanied by orthopedic, gastrointestinal, and respiratory comorbidities. HEPACAM-mutated patients were consistent with the "improving" phenotype. No patients harbored mutations in GPRC5B or AQP4. Our findings expand the mutational spectrum of MLC1, further characterize the disease phenotype, and provide valuable insights into its presence in Italy. They also underscore management needs of individuals with MLC, highlighting the importance of multidisciplinary care.

#2

Astrocyte-specific deletion of LRRC8A causes neurological dysfunction but not chronic white matter edema.

Neurobiology of disease2026 Mar

Volume-regulated anion channels (VRACs) are central to cell volume homeostasis. They mediate swelling-induced efflux of chloride and organic osmolytes to drive regulatory volume decrease. In the brain, VRACs have been proposed to play a key role in astrocytic volume regulation. Genetic defects in astrocytic VRAC modulating proteins (MLC1, GlialCAM, Aquaporin-4, GPRC5B) cause the leukodystrophy Megalencephalic leukoencephalopathy with subcortical cysts (MLC), characterized by chronic white matter edema and myelin vacuolization. Disrupted VRAC activity in MLC-patient-derived lymphoblasts and primary astrocytes from MLC mice further supports a pathogenic link between defective VRAC activity and MLC. Here, we studied the physiological and pathological consequences of astrocyte-specific removal of the essential VRAC subunit LRRC8A. In contrast to established MLC mouse models, astrocyte specific Lrrc8a knockout mice had normal brain water content, no myelin vacuolization, and preserved expression of MLC-related proteins. At a late age they developed a mildly ataxic gait and displayed increased severity of kainate-induced seizures. Two-photon imaging in acute brain slices revealed that astrocytes lacking LRRC8A show normal volume recovery and chloride dynamics upon high potassium-induced cell swelling. Together, these findings demonstrate that astrocyte LRRC8A is not essential for volume regulation in situ and that its loss alone is insufficient to cause the chronic white matter edema typical of MLC. The mild neurological deficits indicate a physiological role for astrocyte LRRC8A, but MLC pathology likely arises from broader dysregulation of the astrocytic protein complex coordinating ion and water homeostasis.

#3

Astrocytes differentiated from patient iPSCs model the rare leukodystrophy MLC and uncover disease-linked maturation defects and Kir4.1 channel dysfunction.

Neurobiology of disease2026 Jan

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare leukodystrophy caused by astrocyte dysfunction. Mutations in the MLC1 gene, which encodes the astrocyte-specific membrane protein MLC1 represent the main cause. MLC is characterized by myelin vacuolation, subcortical cysts, and brain edema. Clinically, patients show motor impairments such as ataxia and spasticity, and epilepsy. Currently, the function of MLC1 and the molecular mechanisms underlying MLC remain poorly understood, limiting therapeutic development. This is especially relevant since symptom reversibility has been observed in some patients. To date, functional studies have mainly relied on mouse models, which do not fully reproduce human pathology. To develop a more relevant disease model, we generated astrocytes from induced pluripotent stem cells (iPSCs) derived from fibroblasts of three healthy donors and three MLC patients. Using molecular, biochemical, electrophysiological, and imaging approaches, we found that MLC astrocytes show impaired volume regulation, cytoplasmic vacuolation, and altered EGF receptor expression, consistent with prior MLC models. Notably, we also revealed endosomal alterations, increased proliferation, and abnormal expression of the critical astrocyte maturation markers EAAT1, GFAP, Cx43, AQP4, and Kir4.1, the latter causing impaired potassium currents in patient-derived cells. These results provide the first evidence that MLC1 mutations alter astrocyte maturation and potassium homeostasis, potentially contributing to disease pathogenesis. Our patient-specific iPSC-derived model offers novel insights into the molecular basis of MLC and highlights the role of MLC1 in astrocyte development. This platform represents a valuable tool for preclinical drug screening and supports the development of personalized therapeutic strategies for this rare leukodystrophy.

#4

Altered Mechanical Properties of Astrocytes Lacking MLC1: Implications for the Leukodystrophy MLC.

Glia2026 Feb

Loss of function of the astrocyte protein MLC1 causes Megalencephalic Leukoencephalopathy with subcortical Cysts (MLC), a leukodystrophy characterized by white matter edema and slow neurological deterioration. MLC1 dysfunction leads to swelling of perivascular astrocyte endfeet and an impaired attachment of endfeet to blood vessels. In isolated primary astrocytes, loss of MLC1 hinders recovery of astrocytes from cell swelling, but the cellular function of MLC1 is not completely understood. MLC1 modulates gating of mechanosensitive ion channels involved in volume regulation. The cytoskeleton plays a crucial role in cell volume regulation, and interactions between the cytoskeleton and cell membrane affect the properties of mechanosensitive ion channels. Therefore, we investigated whether primary Mlc1-null mouse astrocytes show a disruption in their mechanical properties. We measured the mechanical properties of cultured primary astrocytes with an indentation technique and demonstrated that Mlc1-null astrocytes are softer than wild-type astrocytes. Proteomic analysis and western blots confirmed dysregulation of several cytoskeleton-related pathways in Mlc1-null astrocytes. Confocal imaging revealed that the organization of the actin cytoskeleton and microtubule acetylation are unaffected. Instead, in Mlc1-null astrocytes we observed a decrease in the number of focal adhesions, which aid in relaying mechanical forces between the cytoskeleton, cell membrane, and the extracellular matrix (ECM). Inversely, overexpression of MLC1 in HeLa cells led to an increase in focal adhesions. Together, our findings reveal that the mechanical properties of Mlc1-null astrocytes are altered, and that disrupted cytoskeleton-membrane-ECM interactions potentially play a role in the disease. Modulators of astrocyte mechanobiology might therefore hold promise for MLC therapy development.

#5

Regulation of the orphan G-protein-coupled receptor GPRC5B by MLC1 and the cell adhesion molecule GlialCAM in megalencephalic leukoencephalopathy.

The Journal of biological chemistry2026 Jan

Megalencephalic leukoencephalopathy with subcortical cyst (MLC) is a rare leukodystrophy primarily caused by mutations in two genes: MLC1, encoding a membrane protein of unknown function, and GlialCAM, a cell adhesion molecule. Although MLC1 has been implicated in downregulating signaling pathways, its molecular mechanisms remain elusive. Recently, the orphan G-protein-coupled receptor GPRC5B was identified as a novel interactor of both GlialCAM and MLC1, with dominant heterozygous mutations found in MLC patients, suggesting that GlialCAM and MLC1 may regulate cell signaling via GPRC5B. Here, we show that GPRC5B exhibits constitutive activity, which is inhibited by MLC1, likely through interference with GPRC5B oligomerization. Conversely, GlialCAM enhances β-arrestin 2 recruitment, leading to its own mislocalization from cell-cell junctions. MLC-associated GPRC5B mutants show enhanced maturation and increased stability at the plasma membrane, retain normal constitutive activity and responsiveness to MLC1 and GlialCAM but display increased affinity for GlialCAM and localize to cell-cell junctions in its presence. Notably, coexpression of GlialCAM with these mutants does not induce GlialCAM mislocalization. We propose a model in which finely tuned interactions among GPRC5B, GlialCAM, and MLC1 regulate receptor signaling. These findings provide the first biochemical evidence of GlialCAM and MLC1 modulating GPRC5B activity, suggesting a biochemical explanation for the gain-of-function phenotype observed in GPRC5B MLC mutants. Importantly, our work supports the potential of targeting GPRC5B as a therapeutic strategy in MLC.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC112 artigos no totalmostrando 111

2026

Astrocyte-specific deletion of LRRC8A causes neurological dysfunction but not chronic white matter edema.

Neurobiology of disease
2026

Megalencephalic leukoencephalopathy with subcortical cysts: a multicenter Italian experience.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Astrocytes differentiated from patient iPSCs model the rare leukodystrophy MLC and uncover disease-linked maturation defects and Kir4.1 channel dysfunction.

Neurobiology of disease
2026

Altered Mechanical Properties of Astrocytes Lacking MLC1: Implications for the Leukodystrophy MLC.

Glia
2026

Regulation of the orphan G-protein-coupled receptor GPRC5B by MLC1 and the cell adhesion molecule GlialCAM in megalencephalic leukoencephalopathy.

The Journal of biological chemistry
2025

Agrawal Disease (Megalencephalic Leukoencephalopathy with Subcortical Cysts): A Rare Neurological Case Report.

Annals of African medicine
2025

Dominant MLC-causing mutations alter hepaCAM subcellular localization and protein interactome in astrocytes of the developing mouse cortex.

bioRxiv : the preprint server for biology
2025

Uncommon Allies: Van der Knaap Syndrome and Focal Segmental Glomerulosclerosis.

The Journal of the Association of Physicians of India
2025

Breakdown of blood-brain barrier, astrocytic endfeet swelling, and abnormal behaviors by blockade of TROY signaling in TROY-Fc transgenic mice.

Brain, behavior, and immunity
2025

Inherited white matter disorders in Japan: focusing on demyelinating leukodystrophy.

Brain &amp; development
2025

The landscape of pediatric genetic white matter disorders at a tertiary referral hospital in Upper Egypt and the report of 31 novel variants.

Italian journal of pediatrics
2025

Impaired Volume Regulation and Electrophysiology of Astrocytes In Situ in a Mouse Model for Megalencephalic Leukoencephalopathy With Subcortical Cysts.

Glia
2025

Gene therapy rescues brain edema and motor function in a mouse model of megalencephalic leukoencephalopathy with subcortical cysts.

Molecular therapy : the journal of the American Society of Gene Therapy
2024

Megalencephalic Leukoencephalopathy With Subcortical Cysts in an Adult.

Deutsches Arzteblatt international
2025

MLC1 alteration in iPSCs give rise to disease-like cellular vacuolation phenotype in the astrocyte lineage.

bioRxiv : the preprint server for biology
2025

Imaging in atypical van der knaap disease with subependymal nodular heterotopia: A case report.

Radiology case reports
2024

Movement disorders in Megalencephalic Leukoencephalopathy with subcortical cysts - A case series.

Parkinsonism &amp; related disorders
2025

Psychotic attack during the clinical course of megalencephalic leukoencephalopathy with subcortical cysts: a case report.

European child &amp; adolescent psychiatry
2024

Megalencephalic leukoencephalopathy with subcortical cysts: a variant update and review of the literature.

Frontiers in genetics
2024

Homozygous variant of MLC1 results in megalencephalic leukoencephalopathy with subcortical cysts.

Molecular genetics &amp; genomic medicine
2024

Intragenic homozygous duplication in HEPACAM is associated with megalencephalic leukoencephalopathy with subcortical cysts type 2A.

Neurogenetics
2024

Dynamic local mRNA localization and translation occurs during the postnatal molecular maturation of perivascular astrocytic processes.

Glia
2024

Megalencephalic leukoencephalopathy with subcortical cysts protein-1: A new calcium-sensitive protein functionally activated by endoplasmic reticulum calcium release and calmodulin binding in astrocytes.

Neurobiology of disease
2023

Case report: Analysis of a gene variant and prenatal diagnosis in a family with megalencephalic leukoencephalopathy with subcortical cysts.

Frontiers in neurology
2023

Glial Cell Adhesion Molecule (GlialCAM) Determines Proliferative versus Invasive Cell States in Glioblastoma.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2023

The Effect of Interleukin-1 Antagonists on Brain Volume and Cognitive Function in Two Patients With Megalencephalic Leukoencephalopathy With Subcortical Cysts.

Pediatric neurology
2023

Aquaporin-4 and GPRC5B: old and new players in controlling brain oedema.

Brain : a journal of neurology
2023

The Gross, Fine, and Oral Motor Functions in a Patient with Megalencephalic Leukoencephalopathy with Subcortical Cyst: A Case Report.

Iranian journal of child neurology
2023

A novel role for MLC1 in regulating astrocyte-synapse interactions.

Glia
2023

The alpha7 integrin subunit in astrocytes promotes endothelial blood-brain barrier integrity.

Development (Cambridge, England)
2022

Van Der Knaap Disease: Young Male with Megalencephalic Leukoencephalopathy with Subcortical Cysts: A Case Report.

Neurology India
2022

The CaMKII/MLC1 Axis Confers Ca2+-Dependence to Volume-Regulated Anion Channels (VRAC) in Astrocytes.

Cells
2022

GPR37 Receptors and Megalencephalic Leukoencephalopathy with Subcortical Cysts.

International journal of molecular sciences
2022

Megalencephalic leukoencephalopathy with subcortical cysts: the importance of early diagnosis.

Boletin medico del Hospital Infantil de Mexico
2022

Prevalent MLC1 mutation causing autosomal recessive megalencephalic leukoencephalopathy in consanguineous Palestinian families.

Brain &amp; development
2022

Clinicoradiologic Correlation in 22 Egyptian Children With Megalencephalic Leukoencephalopathy With Subcortical Cysts.

Journal of child neurology
2021

Siblings with megalencephalic leukoencephalopathy with subcortical cysts van der Knaap disease.

BJR case reports
2022

Mlc1-Expressing Perivascular Astrocytes Promote Blood-Brain Barrier Integrity.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2022

A homozygous missense variant in the MLC1 gene underlies megalencephalic leukoencephalopathy with subcortical cysts in large kindred: Heterozygous carriers show seizure and mild motor function deterioration.

American journal of medical genetics. Part A
2022

Emergent White Matter Degeneration in the rTg-DI Rat Model of Cerebral Amyloid Angiopathy Exhibits Unique Proteomic Changes.

The American journal of pathology
2021

Transmembrane topology and oligomeric nature of an astrocytic membrane protein, MLC1.

Open biology
2021

Megalencephalic leukoencephalopathy with subcortical cysts is a developmental disorder of the gliovascular unit.

eLife
2022

Novel variants causing megalencephalic leukodystrophy in Sudanese families.

Journal of human genetics
2021

A Very Rare Case of Megalencephalic Leukoencephalopathy With Subcortical Cysts in a Child Born of Non-Consanguineous Marriage in a Non-Predisposed Community.

Cureus
2021

HepaCAM controls astrocyte self-organization and coupling.

Neuron
2021

Identification of the GlialCAM interactome: the G protein-coupled receptors GPRC5B and GPR37L1 modulate megalencephalic leukoencephalopathy proteins.

Human molecular genetics
2021

Clinical and radiological aspects of bilateral temporal abnormalities: pictorial essay.

Radiologia brasileira
2020

Megalencephalic Leukoencephalopathy: Insights Into Pathophysiology and Perspectives for Therapy.

Frontiers in cellular neuroscience
2020

Astrocyte-Oligodendrocyte-Microglia Crosstalk in Astrocytopathies.

Frontiers in cellular neuroscience
2021

Varying perivascular astroglial endfoot dimensions along the vascular tree maintain perivascular-interstitial flux through the cortical mantle.

Glia
2020

Clinical Features and Molecular Genetics of Autosomal Recessive Ataxia in the Turkish Population.

Journal of pediatric neurosciences
2020

Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment.

Oncogene
2020

Van der Knaap Disease (Vanishing White Matter) - Unusual Presentation in a Neonate: A Case Report.

Neurology India
2020

Bipolar disorder in megalencephalic leukoencephalopathy with subcortical cysts: a case report.

BMC psychiatry
2020

Megalencephalic Leukoencephalopathy with Subcortical Cysts Disease-Linked MLC1 Protein Favors Gap-Junction Intercellular Communication by Regulating Connexin 43 Trafficking in Astrocytes.

Cells
2020

White matter abnormality in Jacobsen syndrome assessed by serial MRI.

Brain &amp; development
2020

Epilepsy in children with leukodystrophies.

Journal of neurology
2020

Cerebellar Astrocyte Transduction as Gene Therapy for Megalencephalic Leukoencephalopathy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
2020

[Analysis of a child with megalencephalic leukoencephalopathy with subcortical cyst type 2B caused by HEPACAM variant].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2020

Structural basis for the dominant or recessive character of GLIALCAM mutations found in leukodystrophies.

Human molecular genetics
2019

A Novel Splice-site Mutation on the MLC1 Gene Leading to Exon 9 Skipping and Megalencephalic Leukoencephalopathy with Subcortical Cysts in a Turkish Patient.

Balkan journal of medical genetics : BJMG
2019

Plasma membrane localization of MLC1 regulates cellular morphology and motility.

Molecular brain
2020

An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies.

Expert review of neurotherapeutics
2019

Comparison of zebrafish and mice knockouts for Megalencephalic Leukoencephalopathy proteins indicates that GlialCAM/MLC1 forms a functional unit.

Orphanet journal of rare diseases
2019

Astroglia in Leukodystrophies.

Advances in experimental medicine and biology
2019

Identification in Chinese patients with GLIALCAM mutations of megalencephalic leukoencephalopathy with subcortical cysts and brain pathological study on Glialcam knock-in mouse models.

World journal of pediatrics : WJP
2019

Tumoural transformation in Van der Knaap syndrome.

Neurology India
2019

Megalencephalic leukoencephalopathy with subcortical cysts without macrocephaly: A case study of comorbid Turner's syndrome.

Clinical neurology and neurosurgery
2019

Megalencephalic Leukoencephalopathy with Subcortical Cysts Protein-1 (MLC1) Counteracts Astrocyte Activation in Response to Inflammatory Signals.

Molecular neurobiology
2019

Teaching NeuroImages: A child with macrocephaly and psychomotor development delay.

Neurology
2019

Girl With Progressive Head Enlargement and Gait Disturbance: Clinicoradiological Clues.

Pediatric neurology
2018

Megalencephalic Leucoencephalopathy [Van Der Knaap Disease] in a Non Agarwal Family.

The Journal of the Association of Physicians of India
2018

Transcriptional network analysis of human astrocytic endfoot genes reveals region-specific associations with dementia status and tau pathology.

Scientific reports
2018

GlialCAM/MLC1 modulates LRRC8/VRAC currents in an indirect manner: Implications for megalencephalic leukoencephalopathy.

Neurobiology of disease
2018

Ectopic positioning of Bergmann glia and impaired cerebellar wiring in Mlc1-over-expressing mice.

Journal of neurochemistry
2018

Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.

Annals of neurology
2018

A founder mutation MLC1 c.736delA associated with megalencephalic leukoencephalopathy with subcortical cysts-1 in north Indian kindred.

Clinical genetics
2018

Megalencephalic leukoencephalopathy with subcortical cysts: Characterization of disease variants.

Neurology
2018

Seizures and disturbed brain potassium dynamics in the leukodystrophy megalencephalic leukoencephalopathy with subcortical cysts.

Annals of neurology
2018

Megalencephalic leukoencephalopathy with subcortical cysts: A personal biochemical retrospective.

European journal of medical genetics
2017

Selective expression of eGFP in mouse perivascular astrocytes by modification of the Mlc1 gene using T2A-based ribosome skipping.

Genesis (New York, N.Y. : 2000)
2017

Leukoencephalopathy-causing CLCN2 mutations are associated with impaired Cl- channel function and trafficking.

The Journal of physiology
2017

A Unique Mutational Spectrum of MLC1 in Korean Patients With Megalencephalic Leukoencephalopathy With Subcortical Cysts: p.Ala275Asp Founder Mutation and Maternal Uniparental Disomy of Chromosome 22.

Annals of laboratory medicine
2017

Subacute demyelinating peripheral neuropathy as a novel presentation of late infantile metachromatic leukodystrophy.

Muscle &amp; nerve
2017

A case of megalencephalic leukoencephalopathy with subcortical cysts type 1 was identified with a novel compound heterozygous alteration (c.135delC; c.423+2dupT) in China.

Clinical case reports
2017

Depolarization causes the formation of a ternary complex between GlialCAM, MLC1 and ClC-2 in astrocytes: implications in megalencephalic leukoencephalopathy.

Human molecular genetics
2016

HepaCAM associates with connexin 43 and enhances its localization in cellular junctions.

Scientific reports
2016

The use of targeted genomic capture and massively parallel sequencing in diagnosis of Chinese Leukoencephalopathies.

Scientific reports
2016

Yield and Clinical Utility of Next-Generation Sequencing in Selected Patients With Lung Adenocarcinoma.

Clinical lung cancer
2017

Astrocyte-mediated infantile-onset leukoencephalopathy mouse model.

Glia
2016

Van der Knaap Disease: Megalencephalic Leukoencephalopathy with Subcortical Cysts.

Saudi journal of medicine &amp; medical sciences
2016

The spectrum of leukodystrophies in children: Experience at a tertiary care centre from North India.

Annals of Indian Academy of Neurology
2016

Metabolic, endocrine, and other genetic disorders.

Handbook of clinical neurology
2016

Megalencephalic leukoencephalopathy with cysts in twelve Egyptian patients: novel mutations in MLC1 and HEPACAM and a founder effect.

Metabolic brain disease
2016

Ten Novel Mutations in Chinese Patients with Megalencephalic Leukoencephalopathy with Subcortical Cysts and a Long-Term Follow-Up Research.

PloS one
2016

Malignant transformation in a case of megalencephalic leukoencephalopathy with subcortical cysts: An extreme rarity in a rare disorder.

Annals of Indian Academy of Neurology
2016

[Identification of a novel MLC1 mutation in a Chinese patient affected with megalencephalic leukoencephalopathy with subcortical cysts].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2016

de novo interstitial deletions at the 11q23.3-q24.2 region.

Molecular cytogenetics
2016

Megalencephalic leukoencephalopathy with subcortical cysts.

Acta neurologica Belgica
2016

Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes.

Human molecular genetics
2015

Magnetic resonance imaging findings of two sisters with Van der Knaap leukoencephalopathy.

The neuroradiology journal
2015

Megalencephalic leucoencephalopathy with subcortical cysts: subcortical diffuse leucoencephalopathy associated with white matter cystic degeneration.

BMJ case reports
2015

A Mutation-Positive Child With Megalencephalic Leukoencephalopathy With Subcortical Cysts: Classical Imaging Findings.

Pediatric neurology
2015

MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS WITH HOMOZYGOUS MUTATION (C.448DELC, P.LEU150 SER FSX11) ON EXON 6 OF MLC1 GENE.

Genetic counseling (Geneva, Switzerland)
2015

Van der Knaap disease: a rare disease with atypical features.

BMJ case reports
2015

Leukoencephalopathy associated with 11q24 deletion involving the gene encoding hepatic and glial cell adhesion molecule in two patients.

European journal of medical genetics
2015

[Analysis of MLC1 gene mutation in a Chinese family with megalencephalic leukoencephalopathy with subcortical cysts].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2015

MLC1 protein: a likely link between leukodystrophies and brain channelopathies.

Frontiers in cellular neuroscience
2015

Megalencephalic leukoencephalopathy with subcortical cysts caused by compound heterozygous mutations in MLC1, in patients with and without subcortical cysts in the brain.

Journal of the neurological sciences
2015

Molecular prenatal diagnosis of megalencephalic leukoencephalopathy with subcortical cysts in a child from southwest of Iran.

Clinical case reports
2015

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) - a case with clinical and magnetic resonance imaging (MRI) dissociation.

Arquivos de neuro-psiquiatria
Ver todos os 112 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

IJCVerificada

Pioneiro da triagem neonatal na América Latina (1976). 17 milhões de bebês triados.

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Leucoencefalopatia megalencefálica com cistos subcorticais

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Megalencephalic leukoencephalopathy with subcortical cysts: a multicenter Italian experience.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2026· PMID 41483250mais citado
  2. Astrocyte-specific deletion of LRRC8A causes neurological dysfunction but not chronic white matter edema.
    Neurobiology of disease· 2026· PMID 41654199mais citado
  3. Astrocytes differentiated from patient iPSCs model the rare leukodystrophy MLC and uncover disease-linked maturation defects and Kir4.1 channel dysfunction.
    Neurobiology of disease· 2026· PMID 41371307mais citado
  4. Altered Mechanical Properties of Astrocytes Lacking MLC1: Implications for the Leukodystrophy MLC.
    Glia· 2026· PMID 41331492mais citado
  5. Regulation of the orphan G-protein-coupled receptor GPRC5B by MLC1 and the cell adhesion molecule GlialCAM in megalencephalic leukoencephalopathy.
    The Journal of biological chemistry· 2026· PMID 41314544mais citado
  6. Agrawal Disease (Megalencephalic Leukoencephalopathy with Subcortical Cysts): A Rare Neurological Case Report.
    Ann Afr Med· 2025· PMID 41288430recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2478(Orphanet)
  2. MONDO:0011391(MONDO)
  3. GARD:3445(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q3237080(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Leucoencefalopatia megalencefálica com cistos subcorticais
Compêndio · Raras BR

Leucoencefalopatia megalencefálica com cistos subcorticais

ORPHA:2478 · MONDO:0011391
🇧🇷 Brasil SUS
Internações
890/ano
Prevalência BR
1:60000
Custo SUS
R$ 45.670/internação
Dados
DATASUS 2024
Geral
Prevalência
<1 / 1 000 000
Casos
100 casos conhecidos
Herança
Autosomal dominant, Autosomal recessive
CID-10
E75.2 · Outras esfingolipidoses
CID-11
Ensaios
1 ativos
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1858854
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades